Highs and Lows: The Biotechnology Yearbook 2021

Since 1986, the BioTechnologie Jahrbuch (Biotechnology Yearbook) has been the go-to reference for the industry in the DACH region, trusted for its up-to-date data, biopolitical insights, in-depth reports on global challenges and technologies, as well as interviews and expert commentaries.

Berlin, 30 November 2021 – The biotechnology sector in Germany, Austria, and Switzerland continues its relentless growth – most recently, the successful development and global commercialisation of a COVID-19 vaccine by the German company BioNTech has effectively given the industry a “booster.”

The 34th BioTechnologie Yearbook offers detailed data and insights into the state of the sector in Germany (more on the study here) and Austria, while providing a broad overview of an industry in the DACH region that is far more than just pharmaceuticals. Among other topics, the yearbook explores how to improve financing for market-ready products, the status of Alzheimer’s research, and why alternative bio-based fuels could help mitigate climate change.

Featuring numerous interviews, reports, and photo essays, the 34th BioTechnologie Yearbook also comes in a new, more compact format.

The BioTechnologie Yearbook 2021 is now available in bookstores and online.